Literature DB >> 3216134

Meningitis caused by Absidia corymbifera.

D W Mackenzie1, J F Soothill, J H Millar.   

Abstract

A 56-year-old man developed mucormycotic meningitis caused by Absidia corymbifera and which followed a penetrating head injury. Antibodies to it were detected in the cerebrospinal fluid at titres higher than those found in the serum, thereby suggesting local production of antibody in the subarachnoid space.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3216134     DOI: 10.1016/s0163-4453(88)96570-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia.

Authors:  R Cloughley; J Kelehan; G Corbett-Feeney; M Murray; J Callaghan; P Regan; M Cormican
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Effect of immunosuppression on the clinicopathological changes in experimental zygomycosis in rabbits.

Authors:  J Sondhi; P P Gupta
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

3.  Indirect enzyme-linked immunosorbent assay for zygomycosis.

Authors:  L Kaufman; L F Turner; D W McLaughlin
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

4.  Sequential clinical, haematological, biochemical, immunopathological and histopathological alterations in buffalo calves (Bubalus bubalis) intravenously infected with Absidia corymbifera.

Authors:  P P Gupta; G Singh; S Sodhi; N Sood
Journal:  Trop Anim Health Prod       Date:  1999-06       Impact factor: 1.559

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Absidia Corymbifera in an immune competent accident victim with multiple abdominal injuries: case report.

Authors:  Rita Belfiori; Adelmo Terenzi; Laura Marchesini; Antonella Repetto
Journal:  BMC Infect Dis       Date:  2007-05-25       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.